Background
==========

In terms of epidemiological transition, end-stage cardiovascular disease, including atrial fibrillation, renal disease and heart failure, is becoming more and more frequent.[@b1-cia-12-1297] This condition grows even worse for the aging population, as the incidence and prevalence of most known cardiovascular disorders increase with age.[@b2-cia-12-1297] However in China, we are lacking in evidence for the management of chronic diseases in elderly. Therefore, studies based on elderly Chinese are warranted.

Estimated glomerular filtration rate (eGFR) calculated from serum--creatinine concentration is a convenient approach to assess patients' renal function, which is strongly associated with the occurrence and development of hypertensive target organ damage (TOD).[@b3-cia-12-1297]--[@b6-cia-12-1297] Current hypertension guidelines including the European Society of Hypertension/European Society of Cardiology guidelines advocate the estimation of glomerular filtration rate (GFR) from serum--creatinine concentrations as an effective approach to enhancing risk prediction.[@b6-cia-12-1297],[@b7-cia-12-1297] For decades, the most commonly used eGFR equations were mainly established and validated in Caucasians, such as Cockcroft--Gault, Modification of Diet in Renal Disease (MDRD) and recently emerging Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI).[@b8-cia-12-1297]--[@b10-cia-12-1297] It was reported that Cockcroft--Gault equation is less accurate than the MDRD study equation in elderly people.[@b11-cia-12-1297]--[@b13-cia-12-1297] However, the MDRD equation underestimated the gold standard GFR in Asian population.[@b14-cia-12-1297] The CKD-EPI equation is the most recent equation established for estimating GFR, and the CKD-EPI creatinine equation appears to be more accurate than the MDRD equation, as the accuracy of the CKD-EPI equation is validated in various study populations and clinical conditions.[@b10-cia-12-1297] Moreover, in recent years, some investigators proposed and validated some Asian- or Chinese-modified eGFR equations, which might be more appropriate for Chinese.[@b15-cia-12-1297],[@b16-cia-12-1297]

Nevertheless, which eGFR equation should be used for risk prediction in elderly Chinese is still under debate.[@b17-cia-12-1297] We have documented in the protocol that TOD, as an intermediate state between conventional risk factors (age, smoking, diabetes mellitus \[DM\]) and clinical events, may be a good marker for risk stratification in the elderly.[@b18-cia-12-1297],[@b19-cia-12-1297] It might better represent exposure to risk factors than the risk factor itself.[@b20-cia-12-1297] To make risk assessment in an elderly participant, examining the associations between eGFR and preclinical TOD is essential, as well as dictating which equation to choose. A unique eGFR equation is essential to make the risk prediction and risk score calculation.

To date, there are no studies comparing the eGFR equations in their associations with preclinical TOD in elderly Chinese.[@b13-cia-12-1297] Therefore, based on the existing eGFR equations, we used data from the Northern Shanghai Study to investigate: whether eGFR calculated from newly established eGFR equations associates more strongly with the preclinical hypertensive TOD in a Chinese community-based elderly cohort.

Methods
=======

Study design and participants
-----------------------------

This analysis was nested in the Northern Shanghai Study ([ClinicalTrials.gov](http://ClinicalTrials.gov) Identifier: NCT02368938) under the registered name "Prognosis Factors of Mortality and Cardiovascular Diseases in the Elderly Chinese: the Northern Shanghai Study", which was a prospective, ongoing and multistage community-based study.[@b19-cia-12-1297] This study was approved by the Shanghai Tenth People's Hospital Institutional Review Board.

The study design was described in the protocol already.[@b19-cia-12-1297] Between June 2014 and August 2015, 1,721 subjects were invited, of whom 1,599 (92.9%) were enrolled. In 1,599 participants, 1,586 participants' serum creatinine concentrations were measured. Among these 1,586 participants, 1,579 (99%) had intima-media thickness (IMT), 1,553 (98%) had ankle--brachial index (ABI), 1,577 (99%) had left ventricular mass index (LVMI), 1,537 (97%) had urine albumin to creatinine ratio (UACR) and 1,533 (97%) had pulse wave velocity. All these 1,586 participants had basic anthropometric data, including body weight, body height and office blood pressure. Thus, the final sample size in our analysis was 1,586.

Social, anthropometric and biological parameters
------------------------------------------------

As it was described already, information including sex, age, weight, and height, smoking habits, history of DM, hypertension, cardio- or cerebrovascular diseases and usage of medications was obtained from the questionnaire.[@b19-cia-12-1297] The venous blood and the urine sample were obtained in a fasting state in the morning. Blood creatinine was measured by enzymatic method.

Estimation of GFR
-----------------

To estimate GFR, the MDRD study equation, the derived Chinese-abbreviated MDRD (c-aMDRD) equation, the CKD-EPI equation, the Asian-modified CKD-EPI (aCKD-EPI) equation and the Chinese-modified CKD-EPI (cCKD-EPI) equation were used.[@b8-cia-12-1297],[@b10-cia-12-1297],[@b13-cia-12-1297],[@b15-cia-12-1297]--[@b17-cia-12-1297],[@b21-cia-12-1297]

Measurements of hypertensive TOD
--------------------------------

As previously described, carotid artery IMT was measured using the MyLab 30 Gold Cardiovascular System (Esaote SpA, Genoa, Italy) with a 7.5 MHz transducer.[@b19-cia-12-1297],[@b22-cia-12-1297],[@b23-cia-12-1297] Four-limb blood pressure of participants was measured with VP-1000 (Omron Healthcare, Kyoto, Japan). Carotid--femoral pulse wave velocity (cf-PWV), as a golden standard of arterial stiffness, was performed with applanation tonometry (SphygmoCor, AtCor Medical, Sydney, Australia) according to the European Expert Consensus on Arterial Stiffness.[@b24-cia-12-1297]--[@b26-cia-12-1297] The urine microalbumin to creatinine ratio was calculated from the urine sample test.

Statistical analysis
--------------------

Baseline demographic and clinical characteristics were presented as mean ± standard deviation (SD) or median (interquartile range) for continuous variables and count (percentage) for categorical variables. Relations between eGFR and hypertensive TOD indicators were performed using multivariate regression analysis. Logistic regression analysis was performed to determine the independent relations between different equation-derived eGFRs and the hypertensive TOD. The SD of eGFR values was calculated respectively ([Table S1](#SD1-cia-12-1297){ref-type="supplementary-material"}). To adjust confounders, systolic blood pressure, smoking, body mass index (BMI), DM, low-density lipoprotein cholesterol (LDL-c), urinary albumin, serum calcium, serum phosphorus and hypertension duration were forced into the model. On the other hand, use of age and sex as adjustors for relations between eGFR and TOD, in which eGFR is also calculated from age and sex, would have resulted in adjustments for age and sex effects twice. Thus, we exclude age and sex from the confounders to avoid excessive computation. Maximum likelihood parameter estimates of odds ratios with 95% Wald confidence intervals were calculated. C-statistics were used to assess the discrimination abilities of adjusted logistic models ([Table S2](#SD2-cia-12-1297){ref-type="supplementary-material"}). Akaike information criterion was used to compare the goodness-of-fit among the different models ([Table S3](#SD3-cia-12-1297){ref-type="supplementary-material"}). The area under the curve (AUC) of the receiver operator characteristic (ROC) curves was used to indicate the detection value of eGFR equations. *Z*-test was used to compare the AUCs. Statistical analyses were performed using the SAS software version 9.4 (SAS Institute, Inc., Cary, NC, USA). The two-sided significant level of 5% was considered as the level of statistical significance.

Ethics approval
---------------

This study was approved by the Shanghai Tenth People's Hospital Institutional Review Board. All participants signed a consent form.

Results
=======

Characteristics of the participants and investigated eGFR equations
-------------------------------------------------------------------

Basic anthropometric data and associated disease conditions were available in 1,586 participants ([Table 1](#t1-cia-12-1297){ref-type="table"}), including conventional cardiovascular risk factors, asymptomatic hypertensive TOD, eGFR, diseases and treatment. The present elderly population had an average age of 72.7±6.0 years. Among these community-dwelling elderly, 44.58% (n=707) were male and 22.8% (n=362) were smokers, with an average BMI of 23.9±3.5 kg/m^2^ and an average blood pressure of 134±18/79±9 mmHg ([Table 1](#t1-cia-12-1297){ref-type="table"}). Following the population sample condition, the overall hypertensive TOD conditions are listed ([Table 1](#t1-cia-12-1297){ref-type="table"}). The preliminary values of eGFRs (n=1,586) are listed in [Table 1](#t1-cia-12-1297){ref-type="table"}, and a different profile of eGFRs is also listed. A large proportions of participants with hypertension (52.6%, n=834) and stage 2 CKD (57%, n=904) are also described ([Table 1](#t1-cia-12-1297){ref-type="table"}). The original studies from which the eGFR equation was derived are listed in [Table S4](#SD4-cia-12-1297){ref-type="supplementary-material"}.

Relations between equation-derived eGFRs and preclinical hypertensive TOD
-------------------------------------------------------------------------

As shown in [Table 2](#t2-cia-12-1297){ref-type="table"}, eGFRs calculated from all the equations were inversely associated with cf-PWV and positively associated with ABI after adjusting confounders (*P*\<0.001). eGFRs from CKD-EPI, aCKD-EPI and cCKD-EPI equations were inversely associated with LVMI (*P*\<0.05). eGFRs from the CKD-EPI equation were significantly associated with UACR (*β*=−0.06, *P*=0.01). As for IMT, after adjustment, only eGFRs calculated from the aCKD-EPI equation were significantly associated with IMT (*β*=−0.07, *P*=0.005; [Table 2](#t2-cia-12-1297){ref-type="table"}). Crude linear regression results were consistent with it and are shown in [Table S5](#SD5-cia-12-1297){ref-type="supplementary-material"} (*β*=−0.10, *P*\<0.001 and *β*=−0.08, *P*=0.002 for aCKD-EPI and cCKD-EPI, respectively).

eGFRs and occurrence of carotid hypertrophy
-------------------------------------------

For carotid hypertrophy (IMT ≥0.9 mm), decreased eGFRs from all the equations failed to show an independent association with carotid hypertrophy (all *P*\>0.05; [Table 3](#t3-cia-12-1297){ref-type="table"}). However, eGFRs calculated from aCKD-EPI and cCKD-EPI equations showed a good performance in associations with increased IMT (both *P*\<0.05 versus AUC =0.5, [Figure 1Ai](#f1-cia-12-1297){ref-type="fig"}). Especially for the eGFR from cCKD-EPI, it had a better performance than the other equations (except for aCKD-EPI) in distinguishing carotid hypertrophy (*P*\<0.05 versus AUC of other equations except for aCKD-EPI; [Figure 1Ai and Aii](#f1-cia-12-1297){ref-type="fig"}).

eGFRs and occurrence of lower limb atherosclerosis
--------------------------------------------------

For lower limb atherosclerosis, which was characterized with a lower ABI (≤0.9), decreased eGFRs calculated from all the equations were independently associated with lower limb atherosclerosis (all *P*\<0.001; [Table 3](#t3-cia-12-1297){ref-type="table"}). Moreover, eGFR from all the equations showed a good performance in associations with lower limb atherosclerosis (*P*\<0.05 to *P*\<0.001 versus AUC =0.5; [Figure 1Bi](#f1-cia-12-1297){ref-type="fig"}). Especially, the eGFR from cCKD-EPI showed a better association with lower limb atherosclerosis than eGFRs from other equations except for aCKD-EPI (*P*\<0.05 versus AUC of other equations except for aCKD-EPI; [Figure 1Bi and Bii](#f1-cia-12-1297){ref-type="fig"}).

eGFRs and occurrence of cardiac hypertrophy
-------------------------------------------

For left ventricular hypertrophy, the increased eGFRs from aCKD-EPI and cCKD-EPI equations were independently associated with cardiac hypertrophy (*P*=0.016 and *P*=0.045 for aCKD-EPI and cCKD-EPI, respectively). Moreover, only eGFRs from aCKD-EPI and cCKD-EPI equations showed a good performance for the detection of LVH (both *P*=0.002 versus AUC =0.05; [Figure 1Ci and Cii](#f1-cia-12-1297){ref-type="fig"}).

eGFRs and occurrence of microalbuminuria
----------------------------------------

For microalbuminuria, which was defined as an increased UACR (\>30 mg/g), decrease in eGFRs calculated from all the equations was independently associated with the occurrence of microalbuminuria after confounders were adjusted (*P*=0.02 to *P*\<0.001; [Table 3](#t3-cia-12-1297){ref-type="table"}). The eGFRs from all the equations showed a good performance in distinguishing the occurrence of microalbuminuria (*P*\<0.001 versus AUC =0.5; [Figure 1Di](#f1-cia-12-1297){ref-type="fig"}). However, no significant differences in detection value were found within these equations ([Figure 1Di and Dii](#f1-cia-12-1297){ref-type="fig"}).

eGFRs and occurrence of arterial stiffening
-------------------------------------------

For the arterial stiffening, which was defined as pulse wave velocity (PWV) \>10 m/s, decrease in eGFRs calculated from all the equations was independently associated with arterial stiffening (*P*\<0.001; [Table 3](#t3-cia-12-1297){ref-type="table"}). The eGFRs from all the equations had a good performance in detecting increased PWV (*P*\<0.001 versus AUC =0.5; [Figure 1Ei](#f1-cia-12-1297){ref-type="fig"}), especially eGFRs from the CKD-EPI equation (*P*\<0.05 versus AUC of other four equations; [Figure 1Ei and Eii](#f1-cia-12-1297){ref-type="fig"}).

Performances of the model from a specific eGFR equation to detect different TODs
--------------------------------------------------------------------------------

The discriminatory properties of the adjusted logistic model depended on the choice of TOD and the equation to calculate eGFR ([Table S2](#SD2-cia-12-1297){ref-type="supplementary-material"}). To detect the listed cardiovascular TOD, all the logistic models in which the eGFRs were calculated from different equations showed moderate predictive ability for the discrimination of TOD (C-statistics from 0.613 \[95% CI, 0.536--0.690\] to 0.747 \[95% CI, 0.667--0.828\]). There is a trend that the model had a better performance in detecting microalbuminuria and arterial stiffening (C statistics from 0.707 \[95% CI, 0.680--0.734\] to 0.747 \[95% CI, 0.667--0.828\]). Under most conditions, the goodness-of-fit among the different models showed no significant differences. In particular, eGFRs from the CKD-EPI equation showed the best goodness-of-fit among the different models compared with eGFRs from other equations ([Table S3](#SD3-cia-12-1297){ref-type="supplementary-material"}).

[Figure 2](#f2-cia-12-1297){ref-type="fig"} shows a preliminary performance summary of eGFRs to detect TOD, classified by a specific equation. The eGFRs from aCKD-EPI and cCKD-EPI equations have a good performance for the detection of all the listed hypertensive TOD ([Figure 2D and E](#f2-cia-12-1297){ref-type="fig"}). The eGFRs from other three equations failed to distinguish cardiac hypertrophy and carotid hypertrophy ([Figure 2A--C](#f2-cia-12-1297){ref-type="fig"}).

Discussion
==========

Summary of findings
-------------------

The Northern Shanghai Study is one of the largest ongoing prospective population study in 1,599 community-dwelling elderly Chinese, and it was authorized and municipal funded with prior registration. In the present analysis, we identified that eGFRs from aCKD-EPI and cCKD-EPI have a better linear dependence with IMT. By ROC analysis, the aCKD-EPI and cCKD-EPI showed a better performance for the detection of the listed hypertensive TOD. Therefore, eGFRs from aCKD-EPI and cCKD-EPI equations were better associated with hypertensive TOD compared with other eGFR equations. aCKD-EPI and cCKD-EPI equations may be more helpful for risk stratification.

eGFRs and hypertensive TOD in the previous studies
--------------------------------------------------

As mentioned earlier, CKD affects a large part of the aging population, which has a considerable prevalence of TOD. The associations between eGFR and other TOD have been widely investigated in previous studies and in our analysis, including cf-PWV, UACR, ABI, IMT and LVH.

In our analysis, decreased eGFRs calculated from all the equations were significantly associated with arterial stiffening (increased cf-PWV). This result was consistent with the Health Aging and Body Composition (ABC) study. In the Health ABC study, which consisted of 2,129 elderly adults, PWV was associated with a rapid decline in renal function over a median of 8.9 years (incident rate ratio \[IRR\], 95% CI, 1.39, 1.09--1.77). ABC investigators emphasized the adjustment for blood pressure (BP), and we also adjusted BP in our analysis.[@b27-cia-12-1297]

As for UACR, the association of reduced eGFR and increased albumin to creatinine ratio (ACR) was consistent with previous studies. Reduced eGFR and increased ACR are always accompanied by each other and are also consistent in a trend of risk prediction.[@b28-cia-12-1297],[@b29-cia-12-1297]

Previous studies also proved that low ABI was associated with the decline in eGFR calculated from CKD-EPI equation. In a prospective cohort study consisting of 2,592 participants from the Framingham Offspring cohort, investigators found that, compared to normal ABI, low ABI was associated with 5.73-fold increased odds of rapid eGFR decline (95% CI, 2.77--11.85; *P*\<0.001).[@b30-cia-12-1297] This trend was also consistent with our results.

On the other hand, investigators revealed that for a general community population of 3,629 participants, reduced eGFR calculated from CKD-EPI-derived equations was independently associated with carotid artery thickening. The odds ratio for increased IMT was 1.299 (95% CI, 1.062--1.588).[@b31-cia-12-1297] This result was in line with our finding when taking the community elderly population of our analysis into account.

As for LVH, it was positively associated with renal function decline. Furthermore, in a retrospective study consisting of 300 in- and outpatients, Chinese investigators found that renal function decline (calculated from CKD-EPI) would contribute to pathological LVH in the elderly.[@b3-cia-12-1297] Their finding suggests that LVH is associated with reduced eGFR calculated from the CKD-EPI equation. This conclusion was in accordance with the trend in our analysis.

Possible reasons for the better associations between equations and TOD
----------------------------------------------------------------------

Our results suggested that the aCKD-EPI equation and cCKD-EPI equation were associated better with hypertensive TOD than the other equations in the elderly Chinese community-dwelling population. Such associations have some underlying reasons.

The superiority of CKD-EPI equation-derived eGFR in detecting an increased PWV and left ventricular hypertrophy has been validated. The investigators argued more on the associations between the MDRD equation and the CKD-EPI equation.[@b32-cia-12-1297] Especially, the four-level ethnicity CKD-EPI equation significantly decreased bias in Asians, including Chinese, although the original CKD-EPI equation may not be accurate for Asians.[@b15-cia-12-1297],[@b33-cia-12-1297] Thus, in the four-level ethnicity CKD-EPI equation, the aCKD-EPI equation may be more accurate for elderly Chinese.

In terms of the detection value of eGFR, age and race are important factors that should be considered, as age and race played a vital role in the eGFR calculation. The superiority of cCKD-EPI to detect the elderly's TOD may come from the influence of the population's age profile. The population from which the cCKD-EPI was derived had an average age of 61±12.7 years, and our target population had an average age of 72.7±6.0 years, both of which were \>60 years old. Although the populations of other equations also had elderly participants, the average age was relatively younger. Thus, from the age point of view, the population of the cCKD-EPI study was the most adjacent one to our investigated population ([Table S4](#SD4-cia-12-1297){ref-type="supplementary-material"}).

These associations may also come from the influence of the population's race. Our target population is community-based elderly Chinese. The cCKD-EPI study has a population of Chinese. The validation cohort of aCKD-EPI equation consisted of 675 Chinese and 248 Japanese, which means that the majority of the cohort is Chinese. Therefore, from the race point of view, the populations from which the aCKD-EPI and cCKD-EPI were derived were adjacent to our community-dwelling population ([Table S4](#SD4-cia-12-1297){ref-type="supplementary-material"}). Furthermore, both coefficients of these two equations were calculated from the local population. A previous study revealed that adjusting a coefficient based on the local population would improve their accuracy.[@b33-cia-12-1297] Thus, these associations of these two equations in detecting hypertensive TOD may come from the adjusted coefficients based on the local population.

Strengths and limitations
-------------------------

The present analysis has several strengths. First, this study is the first study comparing the eGFR equations in their associations with preclinical TOD in elderly Chinese. Second, we had a good population consistency of various measurements. We analyzed five major hypertensive TOD in \>97% (97%--99%) of the final 1,586 participants in our analysis. There are also limitations in this study. First, in this study, the serum creatinine concentrations were measured by the enzymatic method, so that we excluded the Cockcroft--Gault equation, which is based on the Jaffe method. Second, our target was to compare the associations between equation-derived eGFRs and TOD; we did not have the data of GFR from inulin clearance. Thus, the superiority is only for the associations with preclinical TOD. Finally, in this study, we should avoid overinterpretation of the present data as the present analysis was cross-sectional in nature; the ROC curves were not particularly impressive. Additionally, a limited number of participants had clinically significant increases in IMT (n=65, 4.12% of the total 1,586 participants). Therefore, future longitudinal analysis and a clinical sample with a high prevalence of TOD are required.

Conclusion
==========

Considering that TOD is a good marker for risk stratification in the elderly, by showing that Chinese specific CKD-EPI equation derived eGFRs were associated better with 5 major preclinical TOD, cCKD-EPI equation and aCKD-EPI equation are more helpful for risk stratification. Future studies may give attention to the detection value of eGFR for future cardiovascular events. And prior interventions and managements for renal diseases in the elderly should also be considered.

Supplementary materials
=======================

###### 

The respectively calculated SDs of eGFR values for the logistic regression

  Total (n=1,586)   IMT (n=1,579)   ABI (n=1,553)   LVMI (n=1,577)   UACR (n=1,537)   Aortic PWV (n=1,533)
  ----------------- --------------- --------------- ---------------- ---------------- ----------------------
  MDRD              20.5683668      20.5557993      20.5548362       20.4855702       20.5961544
  CKD-EPI           14.2426876      14.2090751      14.2406751       14.1873433       14.1307789
  aCKD-EPI          18.0208154      18.0347565      18.0355388       17.9665128       17.9131654
  cCKD-EPI          14.9272658      14.9582379      14.9289286       14.8616948       14.9174066
  c-aMDRD           24.4979976      24.5138248      24.4881662       24.3729941       24.5445129

**Abbreviations:** SD, standard deviation; eGFR, estimated glomerular filtration rate; IMT, intima--media thickness; ABI, ankle--brachial index; LVMI, left ventricular mass index; UACR, urine albumin to creatinine ratio; PWV, pulse wave velocity; MDRD, Modification of Diet in Renal Disease; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; aCKD-EPI, Asian-modified CKD-EPI; cCKD-EPI, Chinese-modified CKD-EPI; c-aMDRD, Chinese-abbreviated MDRD.

###### 

Assessment of the discrimination abilities of adjusted logistic models to detect the cardiovascular TOD

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Total (n=1,586)   Carotid hypertrophy (n=1,579)   Lower limb atherosclerosis (n=1,553)   Cardiac hypertrophy (n=1,577)   Microalbuminuria (n=1,537)   Arterial stiffening (n=1,533)                                                         
  ----------------- ------------------------------- -------------------------------------- ------------------------------- ---------------------------- ------------------------------- --------- ---------------- --------- ---------------- ---------
  MDRD              0.618\                          \<0.001                                0.640\                          \<0.001                      0.685\                          \<0.001   0.738\           \<0.001   0.709\           \<0.001
                    (0.543, 0.693)                                                         (0.604, 0.676)                                               (0.656, 0.713)                            (0.657, 0.819)             (0.682, 0.736)   

  CKD-EPI           0.613\                          0.002                                  0.647\                          \<0.001                      0.686\                          \<0.001   0.747\           \<0.001   0.723\           \<0.001
                    (0.536, 0.690)                                                         (0.611, 0.682)                                               (0.657, 0.714)                            (0.667, 0.828)             (0.696, 0.749)   

  aCKD-EPI          0.615\                          0.002                                  0.647\                          \<0.001                      0.685\                          \<0.001   0.729\           \<0.001   0.707\           \<0.001
                    (0.538, 0.692)                                                         (0.612, 0.681)                                               (0.656, 0.713)                            (0.646, 0.812)             (0.680, 0.734)   

  cCKD-EPI          0.624\                          \<0.001                                0.649\                          \<0.001                      0.685\                          \<0.001   0.724\           \<0.001   0.713\           \<0.001
                    (0.550, 0.699)                                                         (0.614, 0.684)                                               (0.656, 0.714)                            (0.643, 0.805)             (0.685, 0.740)   

  c-aMDRD           0.620\                          \<0.001                                0.644\                          \<0.001                      0.685\                          \<0.001   0.736\           \<0.001   0.707\           \<0.001
                    (0.545, 0.694)                                                         (0.608, 0.680)                                               (0.656, 0.713)                            (0.654, 0.817)             (0.680, 0.734)   
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:** Adjusted confounders: SBP, smoking, BMI and DM for carotid hypertrophy, lower limb atherosclerosis, microalbuminuria and arterial stiffening and sex, SBP, smoking, BMI and DM for cardiac hypertrophy. Considering an increased IMT (IMT ≥0.9 mm) as carotid hypertrophy, a lower ABI (≤0.9) as lower limb atherosclerosis, left ventricular hypertrophy (\>115 g/m^2^ for males and \>95 g/m^2^ for females) as cardiac hypertrophy, an increased UACR (\>30 mg/g) as microalbuminuria and an increased PWV (\>10 m/s) as arterial stiffening.

**Abbreviations:** TOD, target organ damage; MDRD, Modification of Diet in Renal Disease; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; aCKD-EPI, Asian-modified CKD-EPI; cCKD-EPI, Chinese-modified CKD-EPI; c-aMDRD, Chinese-abbreviated MDRD; SBP, systolic blood pressure; BMI, body mass index; DM, diabetes mellitus; IMT, intima--media thickness; ABI, ankle--brachial index; UACR, urine albumin to creatinine ratio; PWV, pulse wave velocity.

###### 

Goodness-of-fit among the different models

  Total (n=1,586)   Carotid hypertrophy (n=1,579)   Lower limb atherosclerosis (n=1,553)   Cardiac hypertrophy (n=1,577)   Microalbuminuria (n=1,537)   Arterial stiffening (n=1,533)                                                 
  ----------------- ------------------------------- -------------------------------------- ------------------------------- ---------------------------- ------------------------------- ----------- --------- ----------- ----------- -----------
  MDRD              521.247                         ns                                     1,421.704                       \<0.01                       1,736.528                       ns          302.080   ns          1,711.694   \<0.01
  CKD-EPI           521.392                         ns                                     1,411.528                       Reference                    1,737.047                       ns          299.038   Reference   1,690.964   Reference
  aCKD-EPI          520.530                         ns                                     1,415.310                       ns                           1,732.407                       Reference   303.961   ns          1,707.235   \<0.01
  cCKD-EPI          519.782                         Reference                              1,415.070                       ns                           1,734.270                       ns          306.967   0.02        1,701.476   \<0.01
  c-aMDRD           521.030                         ns                                     1,419.735                       0.02                         1,738.172                       ns          303.390   ns          1,713.643   \<0.01

**Abbreviations:** AIC, Akaike information criterion; MDRD, Modification of Diet in Renal Disease; ns, not significant; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; aCKD-EPI, Asian-modified CKD-EPI; cCKD-EPI, Chinese-modified CKD-EPI; c-aMDRD, Chinese-abbreviated MDRD.

###### 

List of the eGFR equations in our study

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Equations   eGFR (mL/min/1.73 m^2^)                                                     Participant                              Race                                   Reference
  ----------- --------------------------------------------------------------------------- ---------------------------------------- -------------------------------------- -------------------------------------
  MDRD        186× Scr^−1.154^× age^−0.203^×0.742 (if female) ×1.212 (if black)           Middle aged\                             Black and White                        Group TMoDiRDS[@b35-cia-12-1297]
                                                                                          CKD patients\                                                                   
                                                                                          Age =50.6±12.7 years[@b34-cia-12-1297]                                          

  c-aMDRD     175× Scr^−1.234^× age^−0.179^×0.79 (if female)                              Middle aged\                             Chinese                                Collaboration CeI[@b36-cia-12-1297]
                                                                                          CKD patients\                                                                   
                                                                                          Age =49.9±15.8 years                                                            

  CKD-EPI     Female & Scr ≤0.7: 144 (166 if black) × (Scr/0.7)^−0.329^× (0.993)^age^\    Middle aged\                             Black and White or other               Levey et al[@b37-cia-12-1297]
              Female & Scr \>0.7: 144 (166 if black) × (Scr/0.7)^−1.209^× (0.993)^age^\   CKD patients\                                                                   
              Male & Scr ≤0.9: 141 (163 if black) × (Scr/0.9)^−0.411^× (0.993)^age^\      Age =47±15 years                                                                
              Male & Scr \>0.9: 141 (163 if black) × (Scr/0.9)^−1.209^× (0.993)^age^                                                                                      

  aCKD-EPI    Female & Scr ≤0.7: 151× (Scr/0.7)^−0.328^× (0.993)^age^\                    Middle aged\                             Asian (675 Chinese and 248 Japanese)   Stevens et al[@b38-cia-12-1297]
              Female & Scr \>0.7: 151× (Scr/0.7)^−1.210^× (0.993)^age^\                   CKD patients\                                                                   
              Male & Scr ≤0.9: 149× (Scr/0.9)^−0.412^× (0.993)^age^\                      Age =49±15 years                                                                
              Male & Scr \>0.9: 149× (Scr/0.9)^−1.210^× (0.993)^age^                                                                                                      

  cCKD-EPI    Female & Scr ≤0.7: 94× (Scr/0.7)^−0.511^× (0.998)^age^\                     T2DM CKD patients\                       Chinese                                Liu et al[@b39-cia-12-1297]
              Female & Scr \>0.7: 128× (Scr/0.7)^−0.543^× (0.992)^age^\                   Age =61.0±12.7 years                                                            
              Male & Scr ≤0.9: 117× (Scr/0.9)^−0.277^× (0.994)^age^\                                                                                                      
              Male & Scr \>0.9: 102× (Scr/0.9)^−0.558^× (0.994)^age^                                                                                                      
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** eGFR, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease; CKD, chronic kidney disease; c-aMDRD, Chinese-abbreviated MDRD; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; aCKD-EPI, Asian-modified CKD-EPI; cCKD-EPI, Chinese-modified CKD-EPI.

###### 

Crude relations between equation-eGFR and cardiovascular TOD indicators

  Equations   IMT (n=1,579)   ABI (n=1,553)   LVMI (n=1,577)   UACR (n=1,537)   Aortic PWV (n=1,533)                                       
  ----------- --------------- --------------- ---------------- ---------------- ---------------------- --------- ------- --------- ------- ---------
  MDRD        −0.005          0.84            0.11             \<0.001          −0.06                  0.01      −0.07   0.004     −0.15   \<0.001
  CKD-EPI     −0.03           0.19            0.15             \<0.001          −0.09                  \<0.001   −0.11   \<0.001   −0.22   \<0.001
  aCKD-EPI    −0.10           \<0.001         0.12             \<0.001          −0.09                  \<0.001   −0.07   0.005     −0.17   \<0.001
  cCKD-EPI    −0.08           0.002           0.10             \<0.001          −0.07                  0.003     −0.06   0.03      −0.15   \<0.001
  c-aMDRD     −0.02           0.41            0.10             \<0.001          −0.06                  0.01      −0.07   0.009     −0.13   \<0.001

**Note:** Crude linear regression was performed without adjustment.

**Abbreviations:** eGFR, estimated glomerular filtration rate; TOD, target organ damage; IMT, intima-media thickness; ABI, ankle--brachial index; LVMI, left ventricular mass index; UACR, urine albumin to creatinine ratio; PWV, pulse wave velocity; MDRD, Modification of Diet in Renal Disease; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; aCKD-EPI, Asian-modified CKD-EPI; cCKD-EPI, Chinese-modified CKD-EPI; c-aMDRD, Chinese-abbreviated MDRD.
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###### 

The performance (AUC of the ROC curve) of different eGFRs to detect specific cardiovascular TOD.

**Notes:** Only *P*\<0.05 versus AUC =0.5 of the eGFR equations are shown in the ROC curves. On the left panel (**Ai**, **Bi**, **Ci**, **Di**, **Ei**), only eGFR equations with *P*\<0.05 versus AUC =0.5 are presented in the ROC curves. On the right panel (**Aii**, **Bii**, **Cii**, **Dii**, **Eii**), AUCs of different eGFR equations are presented as histograms of different gray levels. The abbreviation for each equation is under the *x*-axis. The significance is presented at bottom.

**Abbreviations:** AUC, area under the curve; ROC, receiver operator characteristic; eGFR, estimated glomerular filtration rate; TOD, target organ damage; IMT, intima-media thickness; aCKD-EPI, Asian-modified CKD-EPI; cCKD-EPI, Chinese-modified CKD-EPI; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; c-aMDRD, Chinese-abbreviated MDRD; MDRD, Modification of Diet in Renal Disease; ABI, ankle--brachial index; LVH, left ventricular hypertrophy; UACR, urine albumin to creatinine ratio; PWV, pulse wave velocity.
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![The performance (AUC of the ROC curve) of eGFRs from a specific equation to detect a series of cardiovascular TOD.\
**Notes:** (**A**--**C**) eGFRs (calculated from CKD-EPI, MDRD and c-aMDRD equations) versus AUC =0.5 have statistical differences with PWV, ABI and UACR. (**D** and **E**) The AUCs of eGFR (calculated from aCKD-EPI and cCKD-EPI equations) versus AUC =0.5 have statistical differences with all the listed hypertensive TOD. AUCs were classified by each eGFR equation. AUCs of different TODs are presented as histograms of different colors. The abbreviation for each TOD is under the *x*-axis. The significance is presented at bottom.\
**Abbreviations:** AUC, area under the curve; ROC, receiver operator characteristic; eGFR, estimated glomerular filtration rate; TOD, target organ damage; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; MDRD, Modification of Diet in Renal Disease; c-aMDRD, Chinese-abbreviated MDRD; PWV, pulse wave velocity; ABI, ankle--brachial index; UACR, urine albumin to creatinine ratio; aCKD-EPI, Asian-modified CKD-EPI; cCKD-EPI, Chinese-modified CKD-EPI; LVH, left ventricular hypertrophy; IMT, intima-media thickness; ACR, albumin to creatinine ratio.](cia-12-1297Fig2){#f2-cia-12-1297}

###### 

Characteristics of the community-based participants

  ------------------------------------ ---------------
  Sample number (male), n (%)          1,586 (44.58)
  Age (years)                          72.7±6.0
  BMI (kg/m^2^)                        23.9±3.5
  Brachial SBP/DBP (mmHg)              134±18/79±9
  Smoking, n (%)                       362 (22.8)
  TODs                                 
   LVMI (g/m^2^)                       89.96±28.55
   LVH %                               27.5
   Aortic PWV (m/s)                    9.41±2.31
   Increased aortic PWV %              32.4
   IMT (mm)                            0.61±0.15
   Increased IMT %                     4.1
   LABI                                1.04±0.13
   Low ABI %                           18.9
   UACR (mg/g)                         54.9±181.9
   Microalbuminuria %                  38.7
  eGFR, n=1,586                        
   MDRD                                84.02±20.56
   c-aMDRD                             92.45±24.49
   CKD-EPI                             78.18±14.26
   aCKD-EPI                            93.04±18.03
   cCKD-EPI                            76.31±14.92
  Diseases and treatments, n=1,586     
   DM, n (%)                           310 (19.6)
   Hypertensive patients, n (%)        834 (52.6)
   Antihypertensive treatment, n (%)   791 (49.9)
   Stage 2 CKD, n (%)                  904 (57.0)
   Stage 3 or more CKD, n (%)          134 (8.5)
  ------------------------------------ ---------------

**Notes:** Continuous variables are shown as mean ± SD or median (interquartile range) as appropriate. Stage 2 CKD: eGFR 60--89 mL/min/1.73 m^2^ (MDRD) and stage 3 or more CKD: eGFR \<60 mL/min/1.73 m^2^ (MDRD).

**Abbreviations:** BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TOD, target organ damage; LVMI, left ventricular mass index; LVH, left ventricular hypertrophy; PWV, pulse wave velocity; IMT, intima--media thickness; LABI, left ankle brachial index; ABI, ankle--brachial index; UACR, urine albumin to creatinine ratio; eGFR, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease; c-aMDRD, Chinese-abbreviated MDRD; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; aCKD-EPI, Asian-modified CKD-EPI; cCKD-EPI, Chinese-modified CKD-EPI; DM, diabetes mellitus; SD, standard deviation; CKD, chronic kidney disease.

###### 

Relations between equation-eGFR and cardiovascular TOD indicators

  Equations   IMT (n=1,579)   ABI (n=1,553)   LVMI (n=1,577)   UACR (n=1,537)   Aortic PWV (n=1,533)                                 
  ----------- --------------- --------------- ---------------- ---------------- ---------------------- ------ ------- ------ ------- ---------
  MDRD        0.001           0.95            0.12             \<0.001          −0.05                  0.07   −0.04   0.09   −0.14   \<0.001
  CKD-EPI     −0.02           0.42            0.16             \<0.001          −0.06                  0.01   −0.06   0.01   −0.20   \<0.001
  aCKD-EPI    −0.07           0.005           0.12             \<0.001          −0.06                  0.02   −0.03   0.30   −0.17   \<0.001
  cCKD-EPI    −0.05           0.07            0.11             \<0.001          −0.06                  0.02   −0.03   0.28   −0.16   \<0.001
  c-aMDRD     −0.01           0.78            0.11             \<0.001          −0.05                  0.06   −0.03   0.17   −0.13   \<0.001

**Note:** Adjusted confounders: SBP, smoking, BMI, DM, LDL-c, urinary albumin, serum calcium, serum phosphorus and hypertension duration.

**Abbreviations:** eGFR, estimated glomerular filtration rate; TOD, target organ damage; IMT, intima--media thickness; ABI, ankle--brachial index; LVMI, left ventricular mass index; UACR, urine albumin to creatinine ratio; PWV, pulse wave velocity; MDRD, Modification of Diet in Renal Disease; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; aCKD-EPI, Asian-modified CKD-EPI; cCKD-EPI, Chinese-modified CKD-EPI; c-aMDRD, Chinese-abbreviated MDRD; SBP, systolic blood pressure; BMI, body mass index; DM, diabetes mellitus; LDL-c, low-density lipoprotein cholesterol.

###### 

The performance (adjusted logistic regression) of different eGFRs to detect the cardiovascular TODs with a specific number of each assessment

  Total (n=1,586)   Carotid hypertrophy (n=1,579)   Lower limb atherosclerosis (n=1,553)   Cardiac hypertrophy (n=1,577)   Macro-albuminuria (n=1,537)   Arterial stiffening (n=1,533)                                                             
  ----------------- ------------------------------- -------------------------------------- ------------------------------- ----------------------------- ------------------------------- ------- ------------------- --------- ------------------- ---------
  MDRD              1.15 (0.86--1.55)               0.35                                   1.52 (1.30--1.78)               \<0.001                       1.09 (0.96--1.24)               0.19    1.83 (1.26--2.67)   0.002     1.49 (1.30--1.71)   \<0.001
  CKD-EPI           1.12 (0.87--1.43)               0.38                                   1.51 (1.33--1.71)               \<0.001                       1.07 (0.95--1.20)               0.27    1.71 (1.29--2.27)   \<0.001   1.55 (1.38--1.75)   \<0.001
  aCKD-EPI          1.19 (0.91--1.55)               0.20                                   1.52 (1.32--1.74)               \<0.001                       1.17 (1.03--1.32)               0.016   1.59 (1.18--2.16)   0.003     1.48 (1.30--1.68)   \<0.001
  cCKD-EPI          1.26 (0.94--1.69)               0.13                                   1.56 (1.34--1.82)               \<0.001                       1.13 (1.00--1.28)               0.045   1.53 (1.07--2.19)   0.02      1.52 (1.34--1.73)   \<0.001
  c-aMDRD           1.17 (0.87--1.59)               0.30                                   1.56 (1.32--1.83)               \<0.001                       1.02 (0.90--1.16)               0.74    1.77 (1.21--2.60)   0.003     1.47 (1.28--1.69)   \<0.001

**Notes:** Odds ratio is presented as OR (95%CI).

Indicating per 1 SD decrease in eGFR. Adjusted confounders: systolic blood pressure, smoking, BMI, DM, LDL-c, urinary albumin, serum calcium, serum phosphorus and hypertension duration. Considering an increased IMT (IMT ≥0.9 mm) as carotid hypertrophy, a lower ABI (≤0.9) as lower limb atherosclerosis, left ventricular hypertrophy (\>115 g/m^2^ for male and \>95 g/m^2^ for female) as cardiac hypertrophy, an increased UACR (\>30 mg/g) as micro-albuminuria and an increased PWV (\>10 m/s) as arterial stiffening.

**Abbreviations:** BMI, body mass index; TOD, target organ damage; PWV, pulse wave velocity; IMT, intima--media thickness; ABI, ankle--brachial index; UACR, urine albumin to creatinine ratio; eGFR, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; c-aMDRD, Chinese-abbreviated MDRD; aCKD-EPI, Asian-modified CKD-EPI; cCKD-EPI, Chinese-modified CKD-EPI; DM, diabetes mellitus; SD, standard deviation; LDL-c, low-density lipoprotein cholesterol.
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